Did not become law. It stopped in the House of Representatives's Judiciary Committee on October 18, 2017. The 2017–2018 session has ended.
2017–2018 Regular Session
House Bill 1871
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
24 co-sponsors
BERNARD T. O'NEILL, TINA PICKETT, DAVID R. MILLARD, Lynda Schlegel Culver, Greg Rothman, HARRY A. READSHAW III, SUSAN C. HELM, Becky Corbin, STANLEY E. SAYLOR, GEORGE DUNBAR, RYAN E. MACKENZIE, Jack Rader Jr., GARY W. DAY, Carolyn T. Comitta, WILLIAM C. KORTZ II, KAREN BOBACK, TARAH C. TOOHIL, Judy Ward, MARGUERITE CORR QUINN, KATHARINE M. WATSON, R. Lee James, Frank A. Farry, David H. Zimmerman, SHERYL M. DELOZIER
Its course
October 18 to October 18, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action1 action on 1 day
In the House of RepresentativesOct 18 to Oct 18 · stopped0 days
JudiciaryOct 18 to Oct 18 · stopped0 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.